This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Oxford University Innovation Ltd, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2013-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 484 
2 out of 3,696 
Years Active: 2013-2016
Title: Emyr Lloyd-Evans: Innovator in Substrate Reduction Therapy
Introduction
Emyr Lloyd-Evans is a notable inventor based in Oxford, GB. He has made significant contributions to the field of medical research, particularly in the area of substrate reduction therapy. With a total of 2 patents to his name, his work focuses on innovative treatments for complex diseases.
Latest Patents
Lloyd-Evans' latest patents include a groundbreaking invention that provides a compound which is an inhibitor of sphingolipid biosynthesis. This compound is intended for use in the treatment of diseases that exhibit a secondary Niemann-Pick type C disease-like cellular phenotype. His research aims to address critical health challenges through novel therapeutic approaches.
Career Highlights
Throughout his career, Emyr Lloyd-Evans has worked with prestigious organizations such as Oxford University Innovation Limited and the National Institutes of Health, a component of the US Department of Health & Human Services. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Lloyd-Evans has collaborated with esteemed colleagues, including Frances M Platt and Forbes Dennison Porter. These partnerships have enriched his research and fostered innovation in the field.
Conclusion
Emyr Lloyd-Evans stands out as a dedicated inventor whose work in substrate reduction therapy has the potential to transform treatment options for complex diseases. His contributions to medical research continue to inspire advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile